Did Aurora Cannabis (TSX:ACB) Just Kill Green Organic Dutchman (TSX:TGOD)?

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) recently made a pivotal decision that might kill the future of Green Organic Dutchman Holdings Ltd (TSX:TGOD). Is there hope?

| More on:
question marks written reminders tickets

Image source: Getty Images

Last year, Green Organic Dutchman Holdings (TSX:TGOD) was the hottest pot stock on the market. The company went seemingly turned into a $2 billion marijuana power player overnight. But over the last year, shares have shed 70% of their value. Green Organic’s market cap is down to just $700 million. The entire cannabis industry is being squeezed, but actions by competitor Aurora Cannabis (TSX:ACB)(NYSE:ACB) are largely to blame.

On September 4, Aurora liquidated its 10.5% stake in Green Organic and terminated its option to purchase 20% of the company’s cannabis production. This has been an ongoing story, weighing on shares for nearly the entire year. While investors continue to abandon the stock, you should pay close attention. Contrary to popular belief, Green Organic is not dead. By playing the contrarian, you could double or triple the value of your investment over the next 12 months.

Here’s the deal

On January 5, 2018, Aurora took a 17% stake in Green Organic, with options to eventually increase their ownership to more than 50%. The stake was purchase at a historic low of $1.65 per share. The investment also granted Aurora the right to purchase up to 20% of Green Organic’s annual organic cannabis production, although there were escalators that would eventually allow Aurora to purchase as much as one-third of the annual output.

In addition, Aurora also agreed to help the company construct its next-gen grow facilities with the help of its greenhouse design and consulting subsidiary. According to the original press release, “TGOD has the potential to become one of the lowest-cost cannabis producers in Ontario and beyond.”

“Teaming up with Aurora, the industry’s innovation leader, provides us with a stable, supportive shareholder, through whom we have access to best-in-class technologies and industry know-how, which we believe will significantly accelerate our time to market,” said Csaba Reider, President of Green Organic. “The supply agreement with Aurora validates our strategy to produce premium priced organic cannabis. With this significant cornerstone investor and customer, we will be able to leverage our deep consumer packaged goods and brand building experience, as well as Aurora’s well-established brand recognition, to pursue rapid growth.”

The aftermath

Over the next 18 months, Aurora declined to pick up its options. This January, Aurora purchased Whistler Medical for $175 million, eliminating its need to rely on Green Organic for organic cannabis. This September, Aurora walked away from the partnership completely. After losing its biggest long-term partner and potential acquirer, TGOD shares now trade at just 2.9 times 2020 sales. That’s one of the cheapest multiples in the industry.

But all is not lost. As mentioned, Aurora helped Green Organic design and build their facilities. This guidance will likely help the company achieve industry-low production costs, as production ramps in the fourth quarter.

Additionally, Green Organic now has the opportunity to achieve much higher profitability. Under the previous agreement, Aurora had the right to buy one-fifth of TGOD’s production at wholesale prices. According to the company, the deal termination “significantly improves TGOD’s revenue and gross margin mix due to the repatriation of TGOD’s premium organic cannabis previously earmarked for Aurora.” Management believes that the “revenue sharing model with Aurora … would have lowered TGOD’s average selling price and margins.”

In short, this short-term pain may pave the way for long-term gain. The big uncertainty, however, is if Green Organic can replace Aurora as a customer. According to Cowen analyst Vivien Azer, one of the leading voices in the market, cannabis sales should reach $80 billion by 2030. He suspects the U.S. could make marijuana federally legal within a decade. That means over the long term, TGOD will likely have no issues selling its output, even if there are a few lean years in the interim.

If the company can achieve progress next year as production ramps, expect the market to re-rate shares quickly. Based on industry valuation multiples, shares could have 100% or 200% upside. It’s a big risk that requires patience, but the upside is clear.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »